Jupiter Neurosciences
JUNS
13 hedge funds and large institutions have $827K invested in Jupiter Neurosciences in 2026 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
30% more funds holding
Funds holding: 10 → 13 (+3)
15% more capital invested
Capital invested by funds: $716K → $827K (+$111K)
0.04% less ownership
Funds ownership: 0.07% → 0.03% (-0.04%)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$168K |
| 2 |
VF
Virtu Financial
New York
|
+$68.6K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$10.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.08K |
| 5 |
SG
StoneX Group
New York
|
+$6.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vestor Capital
Chicago,
Illinois
|
-$305K |
| 2 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$73.1K |
| 3 |
YAG
Yorkville Advisors Global
Mountainside,
New Jersey
|
-$48.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$17.5K |
JUNS Hedge Fund Activity: Q2 2026 in Review
13 of the 8,325 institutional investors tracked by Wall St. Rank reported a position in Jupiter Neurosciences (JUNS) for Q2 2026, worth a combined $827K — up 15% from $716K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new JUNS positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $168K. The largest seller was Vestor Capital, cutting an estimated $305K.
- 13 institutional investors held Jupiter Neurosciences (JUNS) as of Q2 2026, up from 10 in Q1 2026.
- Funds reported $827K of Jupiter Neurosciences stock for Q2 2026, up 15% quarter-over-quarter.
- 6 funds opened new Jupiter Neurosciences positions in Q2 2026 and 3 closed out, a net change of +3 holders.
- The largest Jupiter Neurosciences buyer in Q2 2026 was Jane Street, an estimated $168K added.
- The largest Jupiter Neurosciences seller in Q2 2026 was Vestor Capital, an estimated $305K sold.
Based on aggregated 13F filings for Q2 2026.